Delivery Order SPE2DR25D1202-SPE2DR26F71NE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Xyosted 75 mg/0.5 mL auto-injector vials with a ceiling value of $1,150.40. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 23, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,191.17 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector units on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,678.14 for Xyosted 75 mg/0.5 mL auto-injector supplies on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price, non-set-aside delivery order will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector pre-filled syringes valued at $1,716.22. This is a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and represents a non-competitive set-aside award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued...
- The Defense Logistics Agency awarded a $1,752.22 delivery order to AmerisourceBergen Drug Corp for Xyosted 50 mg/0.5 mL auto-injectors on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the contractor's Conshohocken, Pennsylvania facility. Xyosted is a testosterone replacement therapy medication delivered via auto-injector, reflecting the Defense...
- The Defense Logistics Agency awarded a $1,061.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xyosted 75 mg/0.5 mL auto-injector pens. The contract, which is not set-aside and represents a non-competitive delivery order, will be completed by August 5, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,642.03 to AmerisourceBergen Drug Corp for the supply of Xyosted 75 mg/0.5 mL auto-injector vials. This firm fixed-price, non-set-aside delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's critical role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xyosted 75 mg/0.5 ml auto-injector vials valued at $1,789.66. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- The Defense Logistics Agency awarded a $1,800.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for Xyosted 75 mg/0.5 mL auto-injector vials. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Xyosted 75 mg/0.5 ml auto-injector units with a ceiling value of $1,346.07. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with performance to be completed by August 27, 2025, at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F71NEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,704.88 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector vials on October 21, 2025, with completion targeted for October 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded pharmaceutical supply transaction under AmerisourceBergen's broader contract vehicle with the agency. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen's role as a major pharmaceutical distributor and federal healthcare solutions provider positions it as a critical vendor within the Defense Health Agency's medical supply chain, particularly for delivering specialized products such as testosterone replacement therapy auto-injectors to support military personnel and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/21/25 |